A Salmonella Typhimurium mutant strain capable of RNAi delivery

References

• Lieberman J, Song E, Lee SK, Shankar P. Interfering with disease: opportunities and roadblocks to harnessing RNA interference. Trends Mol Med 2003; 9:397 - 403; http://dx.doi.org/10.1016/S1471-4914(03)00143-6; PMID: 13129706
   PubMed Web of Science ®Google Scholar
• Chakraborty C. Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing. Curr Drug Targets 2007; 8:469 - 82; http://dx.doi.org/10.2174/138945007780058988; PMID: 17348839
   PubMed Web of Science ®Google Scholar
• Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 2004; 23:4681 - 9; http://dx.doi.org/10.1038/sj.onc.1207616; PMID: 15122332
   PubMed Web of Science ®Google Scholar
• Gondi CS, Lakka SS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Tung CH, Weissleder R, Rao JS. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res 2004; 64:4069 - 77; http://dx.doi.org/10.1158/0008-5472.CAN-04-1243; PMID: 15205313
   PubMed Web of Science ®Google Scholar
• Fleming JB, Shen GL, Holloway SE, Davis M, Brekken RA. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy. Mol Cancer Res 2005; 3:413 - 23; http://dx.doi.org/10.1158/1541-7786.MCR-04-0206; PMID: 16046552
   PubMed Web of Science ®Google Scholar
• Devroe E, Silver PA. Therapeutic potential of retroviral RNAi vectors. Expert Opin Biol Ther 2004; 4:319 - 27; http://dx.doi.org/10.1517/14712598.4.3.319; PMID: 15006726
   PubMed Web of Science ®Google Scholar
• Kargiotis O, Chetty C, Gondi CS, Tsung AJ, Dinh DH, Gujrati M, Lakka SS, Kyritsis AP, Rao JS. Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene 2008; 27:4830 - 40; http://dx.doi.org/10.1038/onc.2008.122; PMID: 18438431
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Z, Han Y, Liang LH, Ji A. Nanoparticle-based delivery system for application of siRNA in vivo. Curr Drug Metab 2010; 11:182 - 96; http://dx.doi.org/10.2174/138920010791110863; PMID: 20359287
   PubMed Web of Science ®Google Scholar
• Lee JM, Yoon TJ, Cho YS. Recent developments in nanoparticle-based siRNA delivery for cancer therapy. Biomed Res Int 2013; 2013:782041; http://dx.doi.org/10.1155/2013/782041; PMID: 23844368
   PubMed Web of Science ®Google Scholar
• Ozpolat B, Sood AK, Lopez-Berestein G. Liposomal siRNA nanocarriers for cancer therapy. Adv Drug Deliv Rev 2014; 66:110 - 6; http://dx.doi.org/10.1016/j.addr.2013.12.008; PMID: 24384374
   PubMed Web of Science ®Google Scholar
• Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci U S A 2007; 104:10170 - 4; http://dx.doi.org/10.1073/pnas.0703867104; PMID: 17548809
   PubMed Web of Science ®Google Scholar
• Yu B, Yang M, Shi L, Yao Y, Jiang Q, Li X, Tang LH, Zheng BJ, Yuen KY, Smith DK, et al. Explicit hypoxia targeting with tumor suppression by creating an “obligate” anaerobic Salmonella Typhimurium strain. Sci Rep 2012; 2:436; http://dx.doi.org/10.1038/srep00436; PMID: 22666539
   PubMed Web of Science ®Google Scholar
• Zhang L, Gao L, Zhao L, Guo B, Ji K, Tian Y, Wang J, Yu H, Hu J, Kalvakolanu DV, et al. Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs. Cancer Res 2007; 67:5859 - 64; http://dx.doi.org/10.1158/0008-5472.CAN-07-0098; PMID: 17575154
   PubMed Web of Science ®Google Scholar
• Ganai S, Arenas RB, Forbes NS. Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. Br J Cancer 2009; 101:1683 - 91; http://dx.doi.org/10.1038/sj.bjc.6605403; PMID: 19861961
   PubMed Web of Science ®Google Scholar
• Cao HD, Yang YX, Lü L, Liu SN, Wang PL, Tao XH, Wang LJ, Xiang TX. Attenuated Salmonella typhimurium carrying TRAIL and VP3 genes inhibits the growth of gastric cancer cells in vitro and in vivo. Tumori 2010; 96:296 - 303; PMID: 20572589
   PubMed Web of Science ®Google Scholar
• Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M, Ash O, Carmichael E, Chakraborty A, Fischer J, et al. Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol 1999; 17:37 - 41; http://dx.doi.org/10.1038/5205; PMID: 9920266
   PubMed Web of Science ®Google Scholar
• Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, Pawelek J, Bermudes D, Brecher SM, Margitich D, Turnier J, et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis 2000; 181:1996 - 2002; http://dx.doi.org/10.1086/315497; PMID: 10837181
   PubMed Web of Science ®Google Scholar
• Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 2002; 20:142 - 52; http://dx.doi.org/10.1200/JCO.20.1.142; PMID: 11773163
   PubMed Web of Science ®Google Scholar
• Loeffler M, Le’Negrate G, Krajewska M, Reed JC. Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth. Cancer Immunol Immunother 2009; 58:769 - 75; http://dx.doi.org/10.1007/s00262-008-0555-9; PMID: 18633610
   PubMed Web of Science ®Google Scholar
• Chen J, Yang B, Cheng X, Qiao Y, Tang B, Chen G, Wei J, Liu X, Cheng W, Du P, et al. Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model. Cancer Sci 2012; 103:325 - 33; http://dx.doi.org/10.1111/j.1349-7006.2011.02147.x; PMID: 22054098
   PubMed Web of Science ®Google Scholar
• Chen J, Wei D, Zhuang H, Qiao Y, Tang B, Zhang X, Wei J, Fang S, Chen G, Du P, et al. Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications. Mol Cell Proteomics 2011; 10:009399; http://dx.doi.org/10.1074/mcp.M111.009399; PMID: 21474796
   PubMedGoogle Scholar
• Hohmann EL, Oletta CA, Miller SI. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 1996; 14:19 - 24; http://dx.doi.org/10.1016/0264-410X(95)00173-X; PMID: 8821644
   PubMed Web of Science ®Google Scholar
• Galán JE, Curtiss R 3rd. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb Pathog 1989; 6:433 - 43; http://dx.doi.org/10.1016/0882-4010(89)90085-5; PMID: 2671582
   PubMed Web of Science ®Google Scholar
• Miller SI, Kukral AM, Mekalanos JJ. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci U S A 1989; 86:5054 - 8; http://dx.doi.org/10.1073/pnas.86.13.5054; PMID: 2544889
   PubMed Web of Science ®Google Scholar
• Miller SI, Loomis WP, Alpuche-Aranda C, Behlau I, Hohmann E. The PhoP virulence regulon and live oral Salmonella vaccines. Vaccine 1993; 11:122 - 5; http://dx.doi.org/10.1016/0264-410X(93)90006-J; PMID: 8438611
   PubMed Web of Science ®Google Scholar
• Miller SI, Mekalanos JJ. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol 1990; 172:2485 - 90; PMID: 2185222
   PubMed Web of Science ®Google Scholar
• Fields PI, Swanson RV, Haidaris CG, Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci U S A 1986; 83:5189 - 93; http://dx.doi.org/10.1073/pnas.83.14.5189; PMID: 3523484
   PubMed Web of Science ®Google Scholar
• Hohmann EL, Oletta CA, Killeen KP, Miller SI. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J Infect Dis 1996; 173:1408 - 14; http://dx.doi.org/10.1093/infdis/173.6.1408; PMID: 8648213
   PubMed Web of Science ®Google Scholar
• Jia H, Li Y, Zhao T, Li X, Hu J, Yin D, Guo B, Kopecko DJ, Zhao X, Zhang L, et al. Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma. Cancer Immunol Immunother 2012; 61:1977 - 87; http://dx.doi.org/10.1007/s00262-012-1256-y; PMID: 22527247
   PubMed Web of Science ®Google Scholar
• Tian Y, Guo B, Jia H, Ji K, Sun Y, Li Y, Zhao T, Gao L, Meng Y, Kalvakolanu DV, et al. Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC. Cancer Gene Ther 2012; 19:393 - 401; http://dx.doi.org/10.1038/cgt.2012.12; PMID: 22555509
   PubMed Web of Science ®Google Scholar
• Li X, Li Y, Wang B, Ji K, Liang Z, Guo B, Hu J, Yin D, Du Y, Kopecko DJ, et al. Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment. J Cancer Res Clin Oncol 2013; 139:971 - 80; http://dx.doi.org/10.1007/s00432-013-1398-0; PMID: 23463096
   PubMed Web of Science ®Google Scholar
• Hannon GJ, Conklin DS. RNA interference by short hairpin RNAs expressed in vertebrate cells. Methods Mol Biol 2004; 257:255 - 66; PMID: 14770011
   PubMedGoogle Scholar
• Provost P, Dishart D, Doucet J, Frendewey D, Samuelsson B, Rådmark O. Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J 2002; 21:5864 - 74; http://dx.doi.org/10.1093/emboj/cdf578; PMID: 12411504
   PubMed Web of Science ®Google Scholar
• Aagaard L, Rossi JJ. RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 2007; 59:75 - 86; http://dx.doi.org/10.1016/j.addr.2007.03.005; PMID: 17449137
   PubMed Web of Science ®Google Scholar
• Kim DH, Rossi JJ. Strategies for silencing human disease using RNA interference. Nat Rev Genet 2007; 8:173 - 84; http://dx.doi.org/10.1038/nrg2006; PMID: 17304245
   PubMed Web of Science ®Google Scholar
• de Fougerolles AR. Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther 2008; 19:125 - 32; http://dx.doi.org/10.1089/hum.2008.928; PMID: 18257677
   PubMed Web of Science ®Google Scholar
• Shankar P, Manjunath N, Lieberman J. The prospect of silencing disease using RNA interference. JAMA 2005; 293:1367 - 73; http://dx.doi.org/10.1001/jama.293.11.1367; PMID: 15769970
   PubMed Web of Science ®Google Scholar
• Li CX, Parker A, Menocal E, Xiang S, Borodyansky L, Fruehauf JH. Delivery of RNA interference. Cell Cycle 2006; 5:2103 - 9; http://dx.doi.org/10.4161/cc.5.18.3192; PMID: 16940756
   PubMed Web of Science ®Google Scholar
• Keates AC, Fruehauf J, Xiang S, Li CJ. TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery. Biotechnol Genet Eng Rev 2008; 25:113 - 27; http://dx.doi.org/10.5661/bger-25-113; PMID: 21412352
   PubMed Web of Science ®Google Scholar
• Xu DQ, Zhang L, Kopecko DJ, Gao L, Shao Y, Guo B, Zhao L. Bacterial delivery of siRNAs: a new approach to solid tumor therapy. Methods Mol Biol 2009; 487:161 - 87; http://dx.doi.org/10.1007/978-1-60327-547-7_8; PMID: 19301647
   PubMedGoogle Scholar
• Jia LJ, Xu HM, Ma DY, Hu QG, Huang XF, Jiang WH, Li SF, Jia KZ, Huang QL, Hua ZC. Enhanced therapeutic effect by combination of tumor-targeting Salmonella and endostatin in murine melanoma model. Cancer Biol Ther 2005; 4:840 - 5; http://dx.doi.org/10.4161/cbt.4.8.1891; PMID: 16210914
   PubMed Web of Science ®Google Scholar
• Morrissey D, O’Sullivan GC, Tangney M. Tumour targeting with systemically administered bacteria. Curr Gene Ther 2010; 10:3 - 14; http://dx.doi.org/10.2174/156652310790945575; PMID: 20156191
   PubMed Web of Science ®Google Scholar
• Groisman EA, Chiao E, Lipps CJ, Heffron F. Salmonella typhimurium phoP virulence gene is a transcriptional regulator. Proc Natl Acad Sci U S A 1989; 86:7077 - 81; http://dx.doi.org/10.1073/pnas.86.18.7077; PMID: 2674945
   PubMed Web of Science ®Google Scholar
• Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000; 97:6640 - 5; http://dx.doi.org/10.1073/pnas.120163297; PMID: 10829079
   PubMed Web of Science ®Google Scholar